- Cool Tool – An Optimized, Chemically-Defined, Animal Component-Free Neural Basal MediumPosted 2 days ago
- Cool Tool – Lynx CDR Connectors to Improve Sterile Fluid Transfer in BiomanufacturingPosted 3 days ago
- Improving Glycosylation Patterns and Consistency Through Media OptimizationPosted 5 days ago
- Cool Tool – Online Cell Culture Media Formulation ToolPosted 1 week ago
- Video – Impact of Chemically Defined Media on Product QualityPosted 2 weeks ago
- Ask the Expert – Media Optimization Can Improve Glycosylation Patterns and Consistency to Impact Protein EfficacyPosted 2 weeks ago
- Digital Biomanufacturing Will Enable Tissue BioprintingPosted 3 weeks ago
- Video – When and Where to Optimize Cell Culture MediaPosted 4 weeks ago
- Cool Tool – SCOUT® technology reduces time to market and increases chance of success for biopharmaceutical productsPosted 4 weeks ago
- Pumping Iron – But Not in the gym: The Critical Roles of Transferrin in Cell Culture MediaPosted 1 month ago
The future of cell culture development? Part I
As we learn more and more about the detailed workings of cells used in biomanufacturing, methods to modify these workings are developed. This recent article from GEN describes some technologies that were unavailable to cell culture scientists in the past; glycoengineering and site-specific integration.
The sequencing of the CHO genome should provide even more opportunities to improve biopharmaceutical production. Several groups have sequenced CHO cell lines; GT Life Sciences collaborated with BGI to sequence CHO-K1 [announcement pdf], while Selexis collaborated with several Swiss institutions to sequence their proprietary “SURECHO-M” line.
These are just a few examples of techniques that can be used to develop cell lines to produce biopharmaceuticals. It should be interesting to see how regulatory agencies treat drug applications that use cell lines that were developed using advanced techniques such as these.